Capstan Medical: Robot Surgeon

History

2024: Product Announcement

On December 11, 2024, Capstan Medical announced the development of a robotic system to replace heart valves. The complex allows carrying out minimally invasive procedures.

Capstan Medical notes that heart disease remains one of the leading causes of death worldwide. At the same time, in the United States alone, more than 7 million people suffer from heart valve diseases. Although many cardiovascular treatments have improved and become less traumatic, traditional heart valve surgery remains highly invasive and is associated with a long recovery period. Standard treatment options in the form of open heart surgery are not suitable for most patients, while catheter therapy is not possible in all cases. Capstan Medical's robotic platform aims to eliminate existing limitations.

𝓲

Фото: capstanmedical.com

The developed solution offers a significantly less invasive alternative to traditional open heart surgery, while providing accurate and reliable placement of the heart valve implant. When using a robotic procedure, the recovery time is significantly reduced and the risk of complications is minimized.

Percutaneous intervention provides an opportunity to significantly expand treatment options for millions of people suffering from heart valve disease. Our full-implant robotic platform can help a huge number of patients, "says Maggie Nixon, CEO of Capstan Medical.

At the same time, Capstan Medical announced the Series C funding round, during which $110 million was raised for development. Eclipse, Yu Galaxy and Intuitive Ventures took part in the investment program.^[1]

Notes